đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The study is being conducted to demonstrate that V221 may be administered c...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00109343
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
The purpose of this trial is to study the safety and immune response to mea...
Status
Completed
Location
Multiple Locations
Start Date
2001-12
Trial ID
NCT00092404
The purpose of this study is to test the safety of a measles, mumps, and ru...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00109278
The purpose of this study is to determine the mumps virus strength at the e...
Status
Completed
Location
Multiple Locations
Start Date
1999-02
Trial ID
NCT00092391
This study will assess the safety and immunogenicity of ProQuad when admini...
Status
Completed
Location
Multiple Locations
Start Date
2000-06
Trial ID
NCT00984295
This study will test the safety, tolerability, and immunogenicity of VARIVA...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00822237
A Study comparing three different doses of ProQuad to concomitant administr...
Status
Completed
Location
Multiple Locations
Start Date
1999-04
Trial ID
NCT00986232
This study will compare Measles, Mumps, Rubella, and Varicella Vaccine (V22...
Status
Completed
Location
Multiple Locations
Start Date
1998-03
Trial ID
NCT00975507
This study will compare three consistency lots of ProQuad to each other as ...
Status
Completed
Location
Multiple Locations
Start Date
2000-03
Trial ID
NCT00985153